CAMBRIDGE, Mass., May 4, 2021 /PRNewswire/ -- nference, the AI-driven health technology company, today announced that it has been named as a finalist in the Fast Company World Changing Ideas Awards in ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference, a science-first software company transforming healthcare data for research and discovery, and Emory Healthcare, the most comprehensive academic health ...
Nference has raised $60 million. The Mayo Clinic-backed series B round positions nference to forge ahead with its effort to capture and analyze health data, including unstructured information, to help ...
It’s been a good end to the year for data analytics firm nference, ending the year as it started: with a $60 million funding round and a deal with the Mayo Clinic. Back in January, Massachusetts-based ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference today announced a strategic research and data science partnership with Parabilis Medicines, Inc. (“Parabilis”) focused on supporting the clinical ...
nference Media Contact: Matt Hurchik info@nference.net The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party ...
EHR data company nference on Wednesday launched its real-world evidence generation platform and expanded its existing partnership with the Mayo Clinic. The platform, dubbed nSights, collects ...
CAMBRIDGE, Mass., March 23, 2021 /PRNewswire/ -- nference, the AI-driven health technology company, today announced publication in EClinicalMedicine of study "Pre-existing conditions are associated ...
This morning nference, maker of a software platform that helps to synthesize biomedical information, scored $60 million in Series C funding. Matrix Capital Management led the round with participation ...
Durham, N.C.-based Duke Health has partnered with data analytics company Nference to advance the academic health system’s research and medical discoveries. Nference has previously collaborated with ...
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. The ...
-- One third of patients taking immediate-release, twice-nightly sodium oxybate discontinued treatment, most often due to lack of efficacy; inability to wake up was most common reason for missing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results